Three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava invasion

Jpn J Clin Oncol. 2008 Jun;38(6):438-44. doi: 10.1093/jjco/hyn038. Epub 2008 May 21.

Abstract

Background: Hepatocellular carcinoma with inferior vena cava invasion is a rare but fatal condition of disease progression. The aim of this study was to analyze the results of treatment for hepatocellular carcinoma with inferior vena cava invasion by three-dimensional conformal radiation therapy.

Methods: From 1990 to 2006, 18 histopathologically confirmed hepatocellular carcinoma patients with inferior vena cava invasion who were unsuitable for surgery were treated by three-dimensional conformal radiation therapy at our hospital with two to four static or dynamic conformal arc fields.

Results: A median total tumor dose of 50 Gy (range 30-60 Gy) was delivered. The progression-free rate was 91.6% among the patients in whom follow-up computed tomography was obtained. Actuarial survival at 1 year was 33.3%, and the median survival period was 5.6 months.

Conclusions: Three-dimensional conformal radiation therapy might offer a chance of long survival for a part of the hepatocellular carcinoma patients with inferior vena cava invasion, since a third of such patients survived more than a year. Additional treatments should be considered to prevent distant metastases and hepatic functional deterioration after three-dimensional conformal radiation therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actuarial Analysis
  • Aged
  • Aged, 80 and over
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / radiotherapy*
  • Carcinoma, Hepatocellular / secondary
  • Disease-Free Survival
  • Female
  • Humans
  • Imaging, Three-Dimensional*
  • Kaplan-Meier Estimate
  • Liver Neoplasms / mortality
  • Liver Neoplasms / pathology
  • Liver Neoplasms / radiotherapy*
  • Male
  • Middle Aged
  • Radiotherapy Dosage
  • Radiotherapy, Conformal* / methods
  • Retrospective Studies
  • Survival Analysis
  • Vascular Neoplasms / mortality
  • Vascular Neoplasms / radiotherapy*
  • Vascular Neoplasms / secondary*
  • Vena Cava, Inferior / pathology*